Get access to our best features
Get access to our best features
Published 3 months ago

Why Is Gilead Sciences Stock Trading Lower Today? - Gilead Sciences (NASDAQ:GILD)

Summary by Benzinga
Gilead Sciences Inc (NASDAQ:GILD) said it paused tumor study enrollment. The Food and Drug Administration (FDA) subsequently requested a partial clinical hold on these trials.  Gilead is reviewing the benefit-risk of magrolimab across all ongoing trials and will provide an update on this assessment as soon as possible. Patients already enrolled in the Gilead-sponsored ELEVATE solid tumor studies and deriving clinical benefit may continue to choo…

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)